249
Views
6
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients

, , , , , , , & show all
Pages 2801-2811 | Received 24 Oct 2017, Accepted 17 Feb 2018, Published online: 04 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Katherine Linder & Premal Lulla. (2021) Myelodysplastic syndrome and immunotherapy novel to next in-line treatments. Human Vaccines & Immunotherapeutics 17:8, pages 2602-2616.
Read now
Xiangchuan He, Longfei Ding, Kangli Cao, Haoran Peng, Chenjian Gu, Yutang Li, Duoduo Li, Lanlan Dong, Xiujing Hong, Xiangwei Wang, Meilan Fu, Chenli Qiu, Cuisong Zhu, Ziling Zhang, Shu Song, Chenguang Wang, Zhengfan Jiang, Youhua Xie, Zhongtian Qi, Chen Zhao, Ping Zhao, Xiaoyan Zhang & Jianqing Xu. (2021) A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerging Microbes & Infections 10:1, pages 1555-1573.
Read now

Articles from other publishers (4)

Sherri Newmyer, Marvin A. Ssemadaali, Harikrishnan Radhakrishnan, Harold S. Javitz & Parijat Bhatnagar. (2022) Electrically regulated cell‐based intervention for viral infections. Bioengineering & Translational Medicine 8:2.
Crossref
Andrew M. Brunner, Heather A. Leitch, Arjan A. van de Loosdrecht & Nicolas Bonadies. (2022) Management of patients with lower-risk myelodysplastic syndromes. Blood Cancer Journal 12:12.
Crossref
Dixita Ishani Viswanath, Hsuan-Chen Liu, David P. Huston, Corrine Ying Xuan Chua & Alessandro Grattoni. (2022) Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials 280, pages 121297.
Crossref
Robert J. Soiffer, Kameron A. Kooshesh & Vincent Ho. (2021) Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX). ImmunoMedicine 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.